| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.001 | 1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.00034 | 1 |